Cargando…
Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease
Vascular metabolic dysfunction presents in various diseases, such as atherosclerosis, hypertension, and diabetes mellitus. Due to the high prevalence of these diseases, it is important to explore treatment strategies to protect vascular function. Resveratrol (RSV), a natural polyphenolic phytochemic...
Autores principales: | Fan, Dongxiao, Liu, Chenshu, Zhang, Zhongyu, Huang, Kan, Wang, Tengyao, Chen, Sifan, Li, Zilun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658204/ https://www.ncbi.nlm.nih.gov/pubmed/36364370 http://dx.doi.org/10.3390/molecules27217524 |
Ejemplares similares
-
Resveratrol Promotes Angiogenesis in a FoxO1-Dependent Manner in Hind Limb Ischemia in Mice
por: Fan, Dongxiao, et al.
Publicado: (2021) -
Protocol for high-throughput screening of ACE2 enzymatic activators to treat COVID-19-induced metabolic complications
por: Chen, Pin, et al.
Publicado: (2022) -
Celastrol directly binds with VAMP7 and RAB7 to inhibit autophagy and induce apoptosis in preadipocytes
por: Liu, Chenshu, et al.
Publicado: (2023) -
Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice
por: Huang, Kan, et al.
Publicado: (2021) -
Enhanced autophagy alleviates injury during hindlimb ischemia/reperfusion in mice
por: Liu, Chenshu, et al.
Publicado: (2019)